Images
Contact
Mitofusin protein 2 (Mfn2), an crucial componet of mitochondrial metabolism related to the onset of type 2 diabetes, is under the spotlight in the journal Diario Médico, thanks to the BioMed Conference on Mitochondrial Autophagy (Barcelona, March 21-23). As many complex diseases such as diabetes, cardiovascular and neurodegenerative diseases, have been associated with alterations in mitochondrial metabolism, proteins involved in degradation and recycling of mitochondria have become possible therapeutic targets.
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
